ScienceIn the Pipeline

What's Next in Drug Discovery

Biopharmaceutical innovation is revolutionizing medical treatment and has ushered in a new era of medicine for patients. With nearly 7,000 medicines in development, 74 percent of which are potentially first-in-class, patients have more reasons to be optimistic than ever before. Medicines are being developed across dozens of therapeutic areas – including cancer, diabetes, cardiovascular, Alzheimer’s disease and more. Find out more about the potential of the biopharmaceutical R&D pipeline below.

Latest From TheBlog

Spending on medicines grew less than one percent in 2017

By Holly Campbell on April 19, 2018

A new era in Alzheimer's innovation

By Andrew Powaleny on April 19, 2018

Video: Barriers to results-based contracts

By Katie Koziara on April 17, 2018